AFP and hepatocellular carcinoma: Alpha‐fetoprotein (AFP), which is the most widely used blood biomarker in HCC, also shows suboptimal performance as a serological test in HCC surveillance because of fluctuations in the AFP levels during hepatitis flares and 10–20% positivity in early‐stage HCC [5].